Dr. Assiri co-authored research on adverse responses to subtoxic concentrations of zinc oxide and nickel oxide nanoparticles in RAW 264.7 cells (Toxics, 2023), and on silver nanoparticle-based combinations with antimicrobial agents against antimicrobial-resistant clinical isolates (Antibiotics, 2022). He also contributed to work presented at the KAUST Research Conference.